Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Capital Employed (2016 - 2025)

China Pharma Holdings' Return on Capital Employed history spans 15 years, with the latest figure at 0.2% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 30.0% year-over-year to 0.2%; the TTM value through Dec 2025 reached 0.2%, up 30.0%, while the annual FY2025 figure was 0.21%, 22.0% up from the prior year.
  • Return on Capital Employed reached 0.2% in Q4 2025 per CPHI's latest filing, up from 0.4% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.02% in Q3 2023 to a low of 0.5% in Q4 2024.
  • Average Return on Capital Employed over 5 years is 0.2%, with a median of 0.19% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: surged 40bps in 2021, then tumbled -42bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.09% in 2021, then plummeted by -167bps to 0.23% in 2022, then soared by 63bps to 0.08% in 2023, then plummeted by -492bps to 0.5% in 2024, then soared by 60bps to 0.2% in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Return on Capital Employed are 0.2% (Q4 2025), 0.4% (Q3 2025), and 0.42% (Q2 2025).